全球髋关节重建市场 - 市场规模（依细分市场）、占有率、监管、偿付、程序、预测（~2033）

髋关节重建或髋关节置换是一种包括置换髋关节受损或患病部分的手术。髋关节重建的类别包括髋关节置换手术中使用的装置（植入物）。髋关节置换术是一种常见的手术，以人工髋关节或植入物取代受损的髋关节。髋骨关节炎（OA）和类风湿性关节炎（RA）盛行率的增加以及创伤病例的增加，推动对髋关节置换植入物的需求增加。

本报告研究和分析了全球髋关节重建市场，提供了有关主要参与者和市场占有率、主要趋势、创新产品和技术以及竞争格局的资讯。

市场模型的主要内容如下。

已上市的髋关节重建设备和不断变化的竞争格局

• 对主要产业趋势的考察
• 依细分市场划分的髋关节重建设备市场年收入和市场前景（2015-2033年）
• 依细分市场划分的手术总数、单位数量、平均售价和市场价值的详细资料

全球、区域和国家层面的特定市场考察

• 依地区细分全球趋势的特定市场定性资讯和国家考察
• 髋关节重建器材市场的SWOT分析
• 髋关节重建器材市场竞争动态的考察与趋势

掌握包括医疗保健系统概述真实情况，促进市场了解。市场进入部分还提供有关偿付政策和监管环境的讯息，能够更深入地研究市场动态。

• 各国医疗保健系统概览
• 依国家/地区划分的偿付政策
• 各国医疗科技监理状况

目标公司

• Zimmer Biomet Holdings Inc
• DePuy Synthes Inc
• Stryker Corp
• Smith & Nephew Plc
• B. Braun Melsungen AG
• Limacorporate SpA
• MicroPort Scientific Corp
• Medacta Group SA
• Corin Group Ltd
• Exactech Inc
• Kyocera Medical Technologies Inc
• Baumer SA
• Waldemar Link GmbH & Co KG
• Amplitude SA S
• United Orthopedic Corp
• Corentec Co Ltd
• 其他

Hip Reconstruction Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Orthopedic Devices therapeutic area.

Hip Reconstruction or Hip Replacement is a procedure which involves replacement of the damaged or diseased parts of the hip joint. The Hip Reconstruction category includes devices (implants) used in the Hip Replacement procedures. A hip replacement is a common type of surgery where a damaged hip joint is replaced with an artificial one or an implant. The increasing prevalence of osteoarthritis (OA) and rheumatoid arthritis (RA), and the growing number of trauma cases are driving an increased demand for hip replacement implants.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insights offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Hip Reconstruction Devices and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Hip Reconstruction Devices market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Hip Reconstruction Devices market.
• Competitive dynamics insights and trends provided for Hip Reconstruction Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered - Zimmer Biomet Holdings Inc, DePuy Synthes Inc, Stryker Corp, Smith & Nephew Plc, B. Braun Melsungen AG, Limacorporate SpA, MicroPort Scientific Corp, Medacta Group SA, Corin Group Ltd, Exactech Inc, Kyocera Medical Technologies Inc, Baumer SA, Waldemar Link GmbH & Co KG, Amplitude SA S, United Orthopedic Corp, Corentec Co Ltd, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Hip Reconstruction marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Hip Reconstruction market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Hip Reconstruction market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
• Track device sales in the global and country-specific Hip Reconstruction market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.